Personalised Oncology

Personalised Oncology

Microscope view of embryonic lung stem cells
In the Personalised Oncology division clinicians and scientists are working together to reduce the impact of cancer in our community.

Our researchers use tumour samples and clinical data to better understand the characteristics of individual patients’ genetic make-up and the genetics of their cancer. We aim to use this insight to progress personalised strategies for the prevention, detection, diagnosis and treatment of cancer.

Health impact

Cancers: bowel cancer, brain cancer, breast cancer, leukaemia, lung cancer, ovarian cancer, pancreatic cancer, prostate cancer, rare cancers, stomach cancer

Immune health and infection: autoinflammatory diseases, chronic infections, Crohn’s disease, inflammatory bowel disease, influenza, rheumatoid arthritis

Development and ageing: multiple sclerosis, regenerative medicine

Other: pneumococcal infections, sickle cell anaemia, immunotherapy, targeted therapy

Division news

Division heads

Professor Peter Gibbs

Associate Professor Marie-Liesse Labat

Lab heads

Professor Tony Burgess

Dr Tracy Putoczki

Associate Professor Oliver Sieber

Dr Ian Street

Division coordinator

Dr Sabine Kelly